/EINPresswire.com/ -- SURREY, UNITED KINGDOM--(Marketwired - Oct 27, 2016) - Angle PLC (AIM: AGL) (OTCQX: ANPCY)

OTCQX: ANPCY

For immediate release  27 October 2016

ANGLE plc
("ANGLE" or the "Company")

Director's share purchase

ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that it was notified today that Andrew Newland, Chief Executive of ANGLE, has purchased 1,350,000 ordinary shares of 10p each in the Company ("Ordinary Shares"). These shares were purchased at a price of 57 pence per share in accordance with the sale and repurchase agreement (the "Agreement"), as described in the Company's announcement of 12 November 2014.

The Agreement has now terminated and Mr Newland's legal and beneficial interest in the Company reverts to the same level as it was prior to the Agreement, being 7,054,686 Ordinary Shares, now representing 9.43 per cent of the Company's issued share capital.

For further information:

ANGLE plc	01483 685830
Andrew Newland, Chief Executive Ian Griffiths, Finance Director
Cenkos Securities Stephen Keys (Nominated adviser) Russell Kerr, Oliver Baxendale (Sales)	020 7397 8900
FTI Consulting Simon Conway, Mo Noonan, Stephanie Cuthbert Kimberley Ha (US)	020 3727 1000 001 212 850 5612

This announcement contains inside information.

This information is provided by RNS
The company news service from the London Stock Exchange
END